Hong Kong Journal of Nephrology
Volume 10, Issue 1 , Pages 7-13, April 2008

Cardiovascular Death in Uremia—More Complex Than We Thought

  • Eberhard Ritz

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr. Eberhard Ritz, Division of Nephrology, Department of Internal Medicine, Ruprecht Karl University of Heidelberg, Im Neuenheimer Feld 162, D-69115 Heidelberg, Germany.

Division of Nephrology, Department of Internal Medicine, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.

Article Outline

A brief overview is provided of the history of cardiovascular complications in renal disease and the underlying pathomechanisms involved in the acceleration of atherogenesis in the earliest stages of renal malfunction. Coronary artery disease versus cardiomyopathy as the cause of cardiac death in renal patients is discussed. Interventions to attenuate the progression of chronic kidney disease, such as blood pressure lowering, treatment with statins and beta-blockers, and blockade of the renin-angiotensin system, are also covered.

Key words:  cardiovascular risk , chronic kidney disease , hemodialysis

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Lindner A , Charra B , Sherrard DJ , Scribner BH . Accelerated atherosclerosis in prolonged maintenance hemodialysis . N Engl J Med . 1974;290:697–701
  2. Sarnak MJ , Levey AS . Cardiovascular disease and chronic renal disease: a new paradigm . Am J Kidney Dis . 2000;35:S117–S131
  3. Keith DS , Nichols GA , Gullion CM , Brown JB , Smith DH . Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization . Arch Intern Med . 2004;164:659–663
  4. Shulman NB , Ford CE , Hall WD , Blaufox MD , Simon D , Langford HG , et al.   Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group . Hypertension . 1989;13(5 Suppl):I80–I93
  5. Van Biesen W , De Bacquer D , Verbeke F , Delanghe J , Lameire N , Vanholder R . The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years . Eur Heart J . 2007;28:478–483
  6. Wright RS , Reeder GS , Herzog CA , Albright RC , Williams BA , Dvorak DL , et al.   Acute myocardial infarction and renal dysfunction: a high-risk combination . Ann Intern Med . 2002;137:563–570
  7. Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M, et al. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial . BMJ . 2006;332:1426
  8. Hallan S , Astor B , Romundstad S , Aasarød K , Kvenild K , Coresh J . Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study . Arch Intern Med . 2007;167:2490–2496
  9. Buzello M , Törnig J , Faulhaber J , Ehmke H , Ritz E , Amann K . The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia . J Am Soc Nephrol . 2003;14:311–316
  10. Bro S , Bentzon JF , Falk E , Andersen CB , Olgaard K , Nielsen LB . Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice . J Am Soc Nephrol . 2003;14:2466–2474
  11. Bursztyn M , Motro M , Grossman E , Shemesh J . Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensives: a 3-year prospective observation . J Hypertens . 2003;21:1953–1959
  12. Kielstein JT , Böger RH , Bode-Böger SM , Frölich JC , Haller H , Ritz E , et al.   Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease . J Am Soc Nephrol . 2002;13:170–176
  13. Kronenberg F , Kuen E , Ritz E , Junker R , König P , Kraatz G , et al.   Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure . J Am Soc Nephrol . 2000;11:105–115
  14. Kronenberg F , Kuen E , Ritz E , König P , Kraatz G , Lhotta K , et al.   Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure . J Am Soc Nephrol . 2002;13:461–469
  15. Klein IH , Ligtenberg G , Oey PL , Koomans HA , Blankestijn PJ . Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension . J Am Soc Nephrol . 2001;12:2427–2433
  16. Shlipak MG , Fried LF , Crump C , Bleyer AJ , Manolio TA , Tracy RP , et al.   Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency . Circulation . 2003;107:87–92
  17. Landray M , Baigent C , Leaper C , Adu D , Altmann P , Armitage J , et al.   The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD . Am J Kidney Dis . 2006;47:385–395
  18. Barker DJ , Bagby SP , Hanson MA . Mechanisms of disease: in utero programming in the pathogenesis of hypertension . Nat Clin Pract Nephrol . 2006;2:700–707
  19. Painter RC , Roseboom TJ , van Montfrans GA , Bossuyt PM , Krediet RT , Osmond C , et al.   Microalbuminuria in adults after prenatal exposure to the Dutch famine . J Am Soc Nephrol . 2005;16:189–194
  20. Brenner BM , Garcia DL , Anderson S . Glomeruli and blood pressure. Less of one, more of the other? . Am J Hypertens . 1988;1:335–347
  21. Keijzer-Veen MG , Schrevel M , Finken MJ , Dekker FW , Nauta J , Hille ET , et al.  Dutch POPS-19 Collaborative Study Group   Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation . J Am Soc Nephrol . 2005;16:2762–2768
  22. Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, et al  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis . N Engl J Med . 2005;353:238–248
  23. Hyre AD , Fox CS , Astor BC , Cohen AJ , Muntner P . The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment . Am J Kidney Dis . 2007;49:37–45
  24. Isbel NM , Haluska B , Johnson DW , Beller E , Hawley C , Marwick TH . Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function . Am Heart J . 2006;151:745–753
  25. Moustapha A , Naso A , Nahlawi M , Gupta A , Arheart KL , Jacobsen DW , et al.   Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease . Circulation . 1998;97:138–141
  26. Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, et al  Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial . JAMA . 2007;298:1163–1170
  27. Teng M , Wolf M , Ofsthun MN , Lazarus JM , Hernán MA , Camargo CA , et al.   Activated injectable vitamin D and hemodialysis survival: a historical cohort study . J Am Soc Nephrol . 2005;16:1115–1125
  28. Li YC , Kong J , Wei M , Chen ZF , Liu SQ , Cao LP . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system . J Clin Invest . 2002;110:229–238
  29. Charra B , Calemard E , Ruffet M , Chazot C , Terrat JC , Vanel T , et al.   Survival as an index of adequacy of dialysis . Kidney Int . 1992;41:1286–1291
  30. Zager PG , Nikolic J , Brown RH , Campbell MA , Hunt WC , Peterson D , et al.   “U” curve association of blood pressure and mortality in hemodialysis patients . Medical Directors of Dialysis Clinic, Inc. Kidney Int . 1998;54:561–569
  31. Port FK , Hulbert-Shearon TE , Wolfe RA , Bloembergen WE , Golper TA , Agodoa LY , et al.   Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients . Am J Kidney Dis . 1999;33:507–517
  32. Klassen PS , Lowrie EG , Reddan DN , DeLong ER , Coladonato JA , Szczech LA , et al.   Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis . JAMA . 2002;287:1548–1555
  33. Tonelli M , Keech A , Shepherd J , Sacks F , Tonkin A , Packard C , et al.   Effect of pravastatin in people with diabetes and chronic kidney disease . J Am Soc Nephrol . 2005;16:3748–3754
  34. Tonelli M . The effect of statins on preservation of kidney function in patients with coronary artery disease . Curr Opin Cardiol . 2006;21:608–612
  35. Gross ML , Meyer HP , Ziebart H , Rieger P , Wenzel U , Amann K , et al.   Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients . Clin J Am Soc Nephrol . 2007;2:121–134
  36. Koch M , Thomas B , Tschope W , Ritz E . Survival and predictors of death in dialysed diabetic patients . Diabetologia . 1993;36:1113–1117
  37. Bragg JL , Maroni BJ , Held PJ , Young EW . Beta-adrenergic antagonist utilization among hemodialysis patients . J Am Soc Nephrol . 2001;12:321a
  38. Cice G , Ferrara L , D'Andrea A , D'Isa S , Di Benedetto A , Cittadini A , et al.   Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial . J Am Coll Cardiol . 2003;41:1438–1444
  39. Converse RL , Jacobsen TN , Toto RD , Jost CM , Cosentino F , Fouad-Tarazi F , et al.   Sympathetic overactivity in patients with chronic renal failure . N Engl J Med . 1992;327:1912–1918
  40. Ritz E , Wanner C . The challenge of sudden death in dialysis patients . Clin J Am Soc Nephrol . 2008;Mar 27; [Epub ahead of print].
  41. Bakris GL , Hart P , Ritz E . Beta blockers in the management of chronic kidney disease . Kidney Int . 2006;70:1905–1913
  42. Solomon SD, Rice MMA, Jablonski K, Jose P, Domanski M, Sabatine M, et al  Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial . Circulation . 2006;114:26–31
  43. Hou FF , Zhang X , Zhang GH , Xie D , Chen PY , Zhang WR , et al.   Efficacy and safety of benazepril for advanced chronic renal insufficiency . N Engl J Med . 2006;354:131–140
  44. Zannad F , Kessler M , Lehert P , Grünfeld JP , Thuilliez C , Leizorovicz A , et al.   Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies . Kidney Int . 2006;70:1318–1324
  45. Maiorca R , Brunori G , Zubani R , Cancarini GC , Manili L , Camerini C , et al.   Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study . Nephrol Dial Transplant . 1995;10:2295–2305
  46. Medcalf JF , Harris KP , Walls J . Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis . Kidney Int . 2001;59:1128–1133
  47. Li PK , Chow KM , Wong TY , Leung CB , Szeto CC . Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study . Ann Intern Med . 2003;139:105–112
  48. Suzuki H , Kanno Y , Sugahara S , Okada H , Nakamoto H . Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD . Am J Kidney Dis . 2004;43:1056–1064
  49. Pun PH , Lehrich RW , Smith SR , Middleton JP . Predictors of survival after cardiac arrest in outpatient hemodialysis clinics . Clin J Am Soc Nephrol . 2007;2:491–500

PII: S1561-5413(08)60013-7

doi:10.1016/S1561-5413(08)60013-7

Hong Kong Journal of Nephrology
Volume 10, Issue 1 , Pages 7-13, April 2008

Article Tools